Nihon Pharmaceutical Co., Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Tokyo Japan (1946)

Organization Overview

First Clinical Trial
2008
NCT00740324
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Nihon Pharmaceutical Co., Ltd